APERIO® Hybrid17|21
Thrombectomy Device
Highly visible nitinol stent retriever
- Full-length visibility
- Hybrid cell design for successful recanalisation*
- Smallest lasercut stent retriever for vessels from 1.0 mm
- For distal thrombectomy
- CE mark approved for vessel diameters from 1.0 - 5.5 mm
- Compatible with 0.0165’’ – 0.027’’ ID microcatheters
* Goertz, L. et al. (2022): Safety and Efficacy of the Novel Low-Profile APERIO Hybrid17 for a Treatment of Proximal and Distal Vessel Occlusion in Acute Ischemic Stroke: A Multi-Center Experience. World Neurosurgery, 2022, Nov; 167 pp. e386-e396
Note:
Not available in the United States.
The information provided on this website relates exclusively to CE-marked products. Product availability, regulatory status and product-specific details may vary from country to country. For information on availability or product-specific details in your country, please contact your local Acandis® representative.
Patient Information and Summaries of Safety and Clinical Performance (SSCPs) about our products can be found here.
Clinical Results
Find publications and clinical studies on our products.
Clinical Experience
with APERIO® Hybrid17 Thrombectomy Devices
Pre treatment
M1, A2-A3 and A4 occlusion
Treatment with
APERIO® Hybrid17 Thrombectomy Device
Post treatment
Final result
Images are courtesy of Dr. Hannes Nordmeyer,
radprax at St. Lukas Hospital Solingen, Germany
Contact
Clinical Support (clinical-support@acandis.com)
Disclaimer:
Please consult the Instructions for Use for all indications, contraindications, warnings, cautions as well as possible adverse effects. Acandis® products are to be used exclusively by trained medical professionals. Orders are taken only in regions where the product is approved.
Please contact an Acandis® representative for product availability.